Greylin Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $966K | Buy |
+9,050
| New | +$966K | 0.16% | 46 |
|
|
2023
Q1 | – | Sell |
-1,392
| Closed | -$222K | – | 74 |
|
|
2022
Q4 | $222K | Sell |
1,392
-686
| -33% | -$109K | 0.04% | 65 |
|
|
2022
Q3 | $277K | Sell |
2,078
-2,105
| -50% | -$281K | 0.06% | 61 |
|
|
2022
Q2 | $653K | Sell |
4,183
-157
| -4% | -$24.5K | 0.13% | 48 |
|
|
2022
Q1 | $676K | Buy |
4,340
+846
| +24% | +$132K | 0.12% | 52 |
|
|
2021
Q4 | $445K | Buy |
3,494
+1,252
| +56% | +$159K | 0.08% | 68 |
|
|
2021
Q3 | $292K | Buy |
2,242
+852
| +61% | +$111K | 0.06% | 82 |
|
|
2021
Q2 | $247K | Buy |
+1,390
| New | +$247K | 0.05% | 87 |
|